Clinical Trials

Blog Post

Simply Stated: Inclusion Body Myositis, Revisited

By Sujatha Gurunathan | April 27, 2022
Blog Post

Promoting Diversity in Rare Disease Research

By Larry Luxner | April 8, 2022
Blog Post

Simply Stated: What is Myotonic Dystrophy?

By Sujatha Gurunathan | March 24, 2022
Clinical & Scientific Conference
Blog Post

2022 Clinical & Scientific Conference: March 16 Highlights

By Sujatha Gurunathan | March 16, 2022
dystrophin
Blog Post

Simply Stated: What is Duchenne Muscular Dystrophy?

By Sujatha Gurunathan | February 16, 2022
Featured Article

A New Direction for Charcot-Marie-Tooth Disease

By MDA Staff | February 16, 2022
Blog Post

Simply Stated: What is Becker Muscular Dystrophy?

By Sujatha Gurunathan | January 6, 2022
Blog Post

FDA Approves argenx’s Vyvgart for Treatment of gMG

By Sujatha Gurunathan | December 20, 2021
Blog Post

Clinical Trial Alert: Early Phase Study of SRP-9001 in Boys with DMD

By Sujatha Gurunathan | November 9, 2021
Blog Post

Clinical Trial Alert: Phase 2/3 Study of Tideglusib (AMO-02) in Children and Adolescents with Congenital Myotonic Dystrophy

By Sujatha Gurunathan | November 9, 2021